Mon, November 8, 2010
[ Mon, Nov 08th 2010 ]: Market Wire
Anika Therapeutics Reports 29% Total Revenue Growth in Third Quarter 2010
[ Mon, Nov 08th 2010 ]: Market Wire
Charles River to Present at Credit Suisse Healthcare Conference
[ Mon, Nov 08th 2010 ]: Market Wire
AGA Medical Reports 2010 Third Quarter Financial Results
[ Mon, Nov 08th 2010 ]: Market Wire
Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2011
[ Mon, Nov 08th 2010 ]: Market Wire
Emeritus Corporation Announces Common Stock Offering
[ Mon, Nov 08th 2010 ]: Market Wire
Clinical Data, Inc. Launches FAMILION® Genetic T .. ompaction and Long QT Syndrome Large Deletion/Dup
[ Mon, Nov 08th 2010 ]: Market Wire
CPEX Pharmaceuticals Reports Third-Quarter 2010 Financial Results
[ Mon, Nov 08th 2010 ]: Market Wire
Progenics Pharmaceuticals Announces Third Quarter 2010 Financial Results
[ Mon, Nov 08th 2010 ]: Market Wire
Transdel Pharmaceuticals Reports Third Quarter and Year-to-Date 2010 Results
[ Mon, Nov 08th 2010 ]: Market Wire
IsoRay Awarded More Than $526,000 in Federal Grants for Breast, Brain and Lung Cancer
[ Mon, Nov 08th 2010 ]: Market Wire
Emergent BioSolutions to Webcast Presentations at Upcoming Investor Conferences
[ Mon, Nov 08th 2010 ]: Market Wire
GTx Appoints Dr. Barry Furr to the Board of Directors
[ Mon, Nov 08th 2010 ]: Market Wire
BioCryst to Present New Data for BCX4208 Monother .. an College of Rheumatology (ACR) Scientific Meeti
[ Mon, Nov 08th 2010 ]: Market Wire
Community Health Systems, Inc. Announces Amendment and Extension of Credit Agreement
[ Mon, Nov 08th 2010 ]: Market Wire
China Kanghui Holdings Announces Board of Director Changes
Sun, November 7, 2010
[ Sun, Nov 07th 2010 ]: Market Wire
Santarus Announces Positive Top-Line Results in E .. y Evaluating Budesonide MMX in Ulcerative Colitis
Sat, November 6, 2010
[ Sat, Nov 06th 2010 ]: Market Wire
GlaxoSmithKline and XenoPort Respond to FDA on Horizanta" for RLS
[ Sat, Nov 06th 2010 ]: Market Wire
XenoPort Announces New Employment Inducement Award
Fri, November 5, 2010
[ Fri, Nov 05th 2010 ]: Market Wire
Alkermesa? Corporate Presentation to be Webcast at the Credit Suisse Healthcare Conference
[ Fri, Nov 05th 2010 ]: Market Wire
Heightened Interest from the Medical Research Com .. ernational Stem Cell Corporationa?s (ISCO) Therap
[ Fri, Nov 05th 2010 ]: Market Wire
Osiris Therapeutics Reports Third Quarter 2010 Financial Results
[ Fri, Nov 05th 2010 ]: Market Wire
Dr. Paul Berg to Retire from Gilead Sciencesa? Board of Directors
[ Fri, Nov 05th 2010 ]: Market Wire
Positron Announces Completion of Cardio-Assista"; Set for Early 2011 Deployment
[ Fri, Nov 05th 2010 ]: Market Wire
Exact Sciences Prices Public Offering of Common Stock
[ Fri, Nov 05th 2010 ]: Market Wire
CORRECTING and REPLACING Response Genetics, Inc. Reports Third Quarter 2010 Financial Results
[ Fri, Nov 05th 2010 ]: Market Wire
ZIOPHARM Reports Third Quarter Financial Results and Updates Clinical Programs
[ Fri, Nov 05th 2010 ]: Market Wire
Orthovita to Present at the Maxim Group 4th Annual Growth Conference
[ Fri, Nov 05th 2010 ]: Market Wire
Alnylam Grants New InterfeRxTM Intellectual Prope .. evelopment and Commercialization of TKM-Ebola, an
[ Fri, Nov 05th 2010 ]: Market Wire
ARCA biopharma Awarded $489,000 Grant under Qualifying Therapeutic Discovery Project
[ Fri, Nov 05th 2010 ]: Market Wire
Emergent BioSolutions Receives Orphan Drug Design .. Monoclonal Antibody for the Treatment of Inhalat
[ Fri, Nov 05th 2010 ]: Market Wire
Synta Pharmaceuticals Reports Third-Quarter 2010 Financial Results and Clinical Update
[ Fri, Nov 05th 2010 ]: Market Wire
Abiomed Reports Record Revenues of $23.4 Million, up 17% for Second Quarter of Fiscal 2011
[ Fri, Nov 05th 2010 ]: Market Wire
Columbia Laboratories Reports Third Quarter 2010 Financial Results
Thu, November 4, 2010
[ Thu, Nov 04th 2010 ]: Market Wire
PRESCIENT NEUROPHARMA INC. ANNOUNCES STOCK OPTION GRANT
[ Thu, Nov 04th 2010 ]: Market Wire
Emergent BioSolutions Reports Financial Results for Third Quarter and First Nine Months of 2010
[ Thu, Nov 04th 2010 ]: Market Wire
Exelixis Announces Third Quarter 2010 Financial Results
[ Thu, Nov 04th 2010 ]: Market Wire
Targacept Reports Third Quarter 2010 Financial Results
[ Thu, Nov 04th 2010 ]: Market Wire
Obagi Medical Products' Third Quarter 2010 Net Sales Rise 12 Percent
[ Thu, Nov 04th 2010 ]: Market Wire
Alkermes Reports Second Quarter Fiscal 2011 Financial Results
[ Thu, Nov 04th 2010 ]: Market Wire
RehabCare to Present at the Stephens Fall Investor Conference 2010
[ Thu, Nov 04th 2010 ]: Market Wire
GenMark Reports Third Quarter Results
[ Thu, Nov 04th 2010 ]: Market Wire
InSite Vision Reports Third Quarter 2010 Financial Results
[ Thu, Nov 04th 2010 ]: Market Wire
Chesley Files Class Action Against DePuy Orthopaedics
[ Thu, Nov 04th 2010 ]: Market Wire
Nasdaq Panel Grants American Learning Corporationa?s Request for Continued Listing
[ Thu, Nov 04th 2010 ]: Market Wire
El Senado de California proclama la semana del 7 .. 3 de noviembre como Semana Educativa sobre la CKD
[ Thu, Nov 04th 2010 ]: Market Wire
Medisafe 1 Technologies to Present Syringe Locking-Device Technology at HealthAchieve Conference
[ Thu, Nov 04th 2010 ]: Market Wire
Medtronic Marks Bladder Health Awareness Month with National Womena?s Health Campaign
[ Thu, Nov 04th 2010 ]: Market Wire
Chemed Corporation to Present at the 2010 Annual Credit Suisse Healthcare Conference
Wed, November 3, 2010
[ Wed, Nov 03rd 2010 ]: Market Wire
Kahn Swick & Foti, LLC and Former Louisiana State .. stors With Large Financial Interests (Over $100,0
[ Wed, Nov 03rd 2010 ]: Market Wire
La vacuna contra el dengue de Sanofi Pasteur est en fase final de desarrollo clnico
[ Wed, Nov 03rd 2010 ]: Market Wire
Sanofi Pasteur's Dengue Vaccine in Final Stage of Clinical Development
[ Wed, Nov 03rd 2010 ]: Market Wire
SurModics and Edge Therapeutics Collaborate on De .. lopment of Sustained-Release Neurological Product
[ Wed, Nov 03rd 2010 ]: Market Wire
Teleflex to Present at the Credit Suisse 2010 Healthcare Conference
[ Wed, Nov 03rd 2010 ]: Market Wire
Eugene Melnyk Delivers Notice of Appeal in OSC Matter
[ Wed, Nov 03rd 2010 ]: Market Wire
Community Health Systems to Participate in Credit Suisse 2010 Healthcare Conference
[ Wed, Nov 03rd 2010 ]: Market Wire
Illumina Introduces TruSeqa" Sample Prep and Exome Enrichment Kits
[ Wed, Nov 03rd 2010 ]: Market Wire
AVEO Pharmaceuticalsa? Tivozanib Recognized as On .. ndhovera?s 2011 Top 10 Oncology Projects to Watch
[ Wed, Nov 03rd 2010 ]: Market Wire
Fibrocell Science, Inc. Establishes Joint Venture to Market Its Technology Platform in Asia
[ Wed, Nov 03rd 2010 ]: Market Wire
CardioNet, Inc. Announces National Reimbursement Rate for Mobile Cardiovascular Telemetry
[ Wed, Nov 03rd 2010 ]: Market Wire
Orthovita Reports 2010 Third Quarter Financial Results And Updates Full Year Financial Guidance
[ Wed, Nov 03rd 2010 ]: Market Wire
BioCryst Awarded $1.1 Million in Grants for Qualifying Therapeutic Development Projects
[ Wed, Nov 03rd 2010 ]: Market Wire
Curis Awarded $500,000 in Grants Under the Patient Protection and Affordable Care Act
[ Wed, Nov 03rd 2010 ]: Market Wire
TSO3 ANNOUNCES FINANCIAL RESULTS FOR Q3 2010
Tue, November 2, 2010
[ Tue, Nov 02nd 2010 ]: Market Wire
Teva Reports Record Third Quarter 2010 Results
[ Tue, Nov 02nd 2010 ]: Market Wire
Insight Imaging Reports Discussions on Potential Restructuring Plan
[ Tue, Nov 02nd 2010 ]: Market Wire
Los compuestos en fase de investigacin GS 9190 y .. tamiento de la hepatitis C en combinacin con trat
[ Tue, Nov 02nd 2010 ]: Market Wire
Array BioPharma to Report Financial Results for t .. First Quarter of Fiscal 2011 on November 8, 2010
[ Tue, Nov 02nd 2010 ]: Market Wire
GenMark Diagnostics Acquires License to HCV Genotyping Patent Estate
[ Tue, Nov 02nd 2010 ]: Market Wire
SurModics to Webcast Fourth Quarter and Fiscal Year 2010 Earnings Conference Call November 10
[ Tue, Nov 02nd 2010 ]: Market Wire
Corgenix to Host Conference Call to Discuss First Quarter Results
[ Tue, Nov 02nd 2010 ]: Market Wire
Notice of Medical Facilities Corporation';s Fisca .. 0 Third Quarter Financial Results Conference Call
[ Tue, Nov 02nd 2010 ]: Market Wire
WellCare Board Adopts Majority Voting Standard for Director Elections
[ Tue, Nov 02nd 2010 ]: Market Wire
Aeolus Pharmaceuticalsa? AEOL 10150 Promotes Surv .. man Primates Exposed to Lethal Doses of Radiation
[ Tue, Nov 02nd 2010 ]: Market Wire
Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Third Qua .. er 2010 Financial Results Call Set for November 9
[ Tue, Nov 02nd 2010 ]: Market Wire
Tolerx Forms Scientific Advisory Board to Advance Research in Type 1 Diabetes
[ Tue, Nov 02nd 2010 ]: Market Wire
Coventry Health Care, Expeditors International, A .. source Bergen, Principal Financial and Kellogga?s
[ Tue, Nov 02nd 2010 ]: Market Wire
Neurocrine Biosciences, Jacobs Engineering, Ford, Kellogg and Honda Motor Co.
[ Tue, Nov 02nd 2010 ]: Market Wire
DUSA Pharmaceuticals, Inc.® to Host Third Quarte .. Highlights and Financial Results Conference Call
Mon, November 1, 2010
[ Mon, Nov 01st 2010 ]: Market Wire
Prestige Brands Holdings, Inc. Completes Purchase of Blacksmith Brands
[ Mon, Nov 01st 2010 ]: Market Wire
Biomagnetics Completes Audit and Financial Review
[ Mon, Nov 01st 2010 ]: Market Wire
NeoStem to Present at Cell Therapy Industry Summi .. eld on November 3-5, 2010 in Carlsbad, California
[ Mon, Nov 01st 2010 ]: Market Wire
Clinical Data, Inc. Granted Orphan Drug Designati .. for PRX-8066 for Pulmonary Arterial Hypertension
[ Mon, Nov 01st 2010 ]: Market Wire
Health Management Associates, Inc. to Present at the Oppenheimer 21st Annual Healthcare Conference
[ Mon, Nov 01st 2010 ]: Market Wire
Two Directors Step Down from Elan Board in Accordance with Previously Announced Intention
[ Mon, Nov 01st 2010 ]: Market Wire
I composti sperimentali per l'epatite C di Gilead .. azione con terapie standard di cura ottengono una
[ Mon, Nov 01st 2010 ]: Market Wire
Theragenics to Report Third Quarter 2010 Financial Results Tuesday, November 9
[ Mon, Nov 01st 2010 ]: Market Wire
Orthovita to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
[ Mon, Nov 01st 2010 ]: Market Wire
ARIAD to Webcast Conference Call on Third Quarter 2010 Financial Results
[ Mon, Nov 01st 2010 ]: Market Wire
Hepatitis-C-Prfprparate GS 9190 und GS 9256 von G .. Phase II zusammen mit Standardtherapien wesentli
[ Mon, Nov 01st 2010 ]: Market Wire
American Anesthesiology Announces the Acquisition of Greensboro, NC, Group Practice
[ Mon, Nov 01st 2010 ]: Market Wire
Inhibitex Initiates Phase 1b Multiple Ascending D .. l of INX-189 in Patients with Chronic Hepatitis C
[ Mon, Nov 01st 2010 ]: Market Wire
Medisafe 1 Technologies Appoints Tali Skoczylas as Chair of Medical Advisory Board
[ Mon, Nov 01st 2010 ]: Market Wire
Porex Corporation Divests Surgical Division to Stryker Corporation
Sat, October 30, 2010
[ Sat, Oct 30th 2010 ]: Market Wire
A Celgene anuncia resultados financeiros e operacionais recordes no terceiro trimestre de 2010
[ Sat, Oct 30th 2010 ]: Market Wire
Viread® for Hepatitis B Maintains Antiviral Supp .. ent of Resistance Through Four Years of Treatment
[ Sat, Oct 30th 2010 ]: Market Wire
Gileada?s Investigational Hepatitis C Compounds G .. tion with Standard of Care Therapies Achieve Subs
[ Sat, Oct 30th 2010 ]: Market Wire
Salix Pharmaceuticals Previews Data Slated for Pr .. ting of the American Association for the Study of
[ Sat, Oct 30th 2010 ]: Market Wire
New Data From Phase 3 Studies Showed Superior SVR .. with Telaprevir-Based Combination Therapy in Peop
Fri, October 29, 2010
[ Fri, Oct 29th 2010 ]: Market Wire
Fitch Affirms Boston Scientific's IDR at 'BB+'; Outlook to Positive
[ Fri, Oct 29th 2010 ]: Market Wire
Teva Invites Public to Listen to Its Respiratory Opportunity Meeting Webcast
[ Fri, Oct 29th 2010 ]: Market Wire
Ligand to Report Third Quarter Results on November 9
[ Fri, Oct 29th 2010 ]: Market Wire
St. Jude Medical???2010??????????????
[ Fri, Oct 29th 2010 ]: Market Wire
Celgene meldet rekordverdchtiges Betriebs- und Finanzergebnis fr das dritte Quartal 2010
[ Fri, Oct 29th 2010 ]: Market Wire
Seattle Genetics to Present at Oppenheimer Healthcare Conference
[ Fri, Oct 29th 2010 ]: Market Wire
Idera Pharmaceuticals Appoints Sudhir Agrawal as .. Directors and William S. Reardon as Lead Director
[ Fri, Oct 29th 2010 ]: Market Wire
Alnylam Scientists to Present New Data on RNAi Th .. Meeting of the American Association for the Stud
[ Fri, Oct 29th 2010 ]: Market Wire
MannKind Corporation Reports 2010 Third Quarter Financial Results
[ Fri, Oct 29th 2010 ]: Market Wire
Abstracts Highlighting Data from Enzona?s mRNA An .. d for Presentation at 2010 EORTC-NCI-AACR Meeting
[ Fri, Oct 29th 2010 ]: Market Wire
Celgene Corporation to Present at Oppenheimera?s 21st Annual Healthcare Conference
[ Fri, Oct 29th 2010 ]: Market Wire
Compugen Licenses Novel Oncology Target to Seattle Genetics
[ Fri, Oct 29th 2010 ]: Market Wire
Magellan Health Services Reports Third Quarter 2010 Financial Results
[ Fri, Oct 29th 2010 ]: Market Wire
Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference
Thu, October 28, 2010
[ Thu, Oct 28th 2010 ]: Market Wire
AGA Medical to Report Third Quarter Earnings on Monday, November 8, 2010
[ Thu, Oct 28th 2010 ]: Market Wire
Urologix to Host Its Fiscal 2011 First Quarter Conference Call
[ Thu, Oct 28th 2010 ]: Market Wire
Exact Sciences Reports Positive Results for Colorectal Cancer Screening Test
[ Thu, Oct 28th 2010 ]: Market Wire
Health Net Expands Mobile Capabilities
[ Thu, Oct 28th 2010 ]: Market Wire
Emeritus Corporation to Host Third Quarter 2010 Earnings Conference Call and Webcast
[ Thu, Oct 28th 2010 ]: Market Wire
ArthroCare Receives FDA Clearance for Spartan PEEK Suture Implant
[ Thu, Oct 28th 2010 ]: Market Wire
Celgene Reports Record Third Quarter 2010 Operating and Financial Results
[ Thu, Oct 28th 2010 ]: Market Wire
Celgene comunica risultati finanziari e operativi record per il terzo trimestre del 2010
[ Thu, Oct 28th 2010 ]: Market Wire
Natus Medical Announces 2010 Third Quarter Financial Results
[ Thu, Oct 28th 2010 ]: Market Wire
Curis Reports Third Quarter 2010 Financial Results
[ Thu, Oct 28th 2010 ]: Market Wire
Pro-Pharmaceuticals Ships First Commercial Order for DAVANAT®
[ Thu, Oct 28th 2010 ]: Market Wire
ACADIA Pharmaceuticals Enters Agreement with Biov .. and Regain North American Rights to Pimavanserin
[ Thu, Oct 28th 2010 ]: Market Wire
BioCryst Reports Third Quarter 2010 Financial Results and Provides Corporate Update
[ Thu, Oct 28th 2010 ]: Market Wire
AngioDynamics Announces Election of Kevin J. Gould to Board of Directors
Wed, October 27, 2010
[ Wed, Oct 27th 2010 ]: Market Wire
Crown Oil and Gas Announces Appointment of Director
[ Wed, Oct 27th 2010 ]: Market Wire
Alnylam to Webcast Conference Call Discussing Third Quarter 2010 Financial Results
[ Wed, Oct 27th 2010 ]: Market Wire
Northstar Healthcare Announces Senior Management Changes
[ Wed, Oct 27th 2010 ]: Market Wire
Neue therapeutische Oberflche von KCI verbessert .. tegritt fr Prvention und Management von Dekubitus
[ Wed, Oct 27th 2010 ]: Market Wire
Nuova superficie terapeutica sviluppata da KCI ri .. la prevenzione e la gestione delle piaghe da dec
[ Wed, Oct 27th 2010 ]: Market Wire
ZIOPHARM Oncology to Present at Oppenheimer 21st Annual Healthcare Conference
[ Wed, Oct 27th 2010 ]: Market Wire
Bond Labsa? Resurrectiona" Conducts In-Store Promotions for Cub Foods®
[ Wed, Oct 27th 2010 ]: Market Wire
Successful IsoRay Study of Cesium-131 Internal Ra .. Breast CancerPaves the Way for Advanced Treatment
[ Wed, Oct 27th 2010 ]: Market Wire
Exact Sciences Reports Third-Quarter 2010 Financial Results
[ Wed, Oct 27th 2010 ]: Market Wire
St. Jude Medical to Showcase Portfolio of Products at Asia-Pacific Heart Rhythm 2010
[ Wed, Oct 27th 2010 ]: Market Wire
Salix Pharmaceuticals Launches Corporate Twitter Account and Facebook Page
[ Wed, Oct 27th 2010 ]: Market Wire
PATIENT HOME MONITORING ANNOUNCES THE NOMINATION OF ADDITIONAL MEMBERS TO THE BOARD OF DIRECTORS
[ Wed, Oct 27th 2010 ]: Market Wire
BioCrysta?s Partner Shionogi Receives Approval for Pediatric Use Of Peramivir in Japan
[ Wed, Oct 27th 2010 ]: Market Wire
Santarus to Hold Third Quarter 2010 Financial Results Conference Call on November 8
Tue, October 26, 2010
[ Tue, Oct 26th 2010 ]: Market Wire
IPC The Hospitalist Company CEO Dr. Adam Singer Named MGMA-ACMPE Physician Executive of the Year
[ Tue, Oct 26th 2010 ]: Market Wire
ARIAD Announces Pricing of Public Offering of Common Stock
[ Tue, Oct 26th 2010 ]: Market Wire
PPD and Bend Research Enter into Collaboration to .. ion Development and Analytical Testing Capabiliti
[ Tue, Oct 26th 2010 ]: Market Wire
PPD and VirtualScopics Establish Strategic Alliance for Medical Imaging Services
[ Tue, Oct 26th 2010 ]: Market Wire
Obagi Medical Products Announces Proposed Seconda .. ockholders and Authorization to Repurchase Shares
[ Tue, Oct 26th 2010 ]: Market Wire
Life Technologies Establishes New Standard for Single-Read Accuracy in Next Generation Sequencing
[ Tue, Oct 26th 2010 ]: Market Wire
Oncolytics Biotech® Inc. Collaborators Prese .. al Colorectal Cancer Study at the International S
[ Tue, Oct 26th 2010 ]: Market Wire
Exelixis Announces November 4 Webcast of Third Quarter 2010 Financial Results Conference Call
[ Tue, Oct 26th 2010 ]: Market Wire
Biogen Idec Reports Third Quarter 2010 Results
[ Tue, Oct 26th 2010 ]: Market Wire
Amedisys Reports Third Quarter Revenue and Earnings, Updates 2010 Guidance
[ Tue, Oct 26th 2010 ]: Market Wire
Compugen Reports Third Quarter 2010 Financial Results
[ Tue, Oct 26th 2010 ]: Market Wire
Synergetics USA Announces New Products and Record .. rican Academy of Ophthalmology 2010 Annual Meetin
[ Tue, Oct 26th 2010 ]: Market Wire
Cascade Technologies Corporation Announces Appointment of Robert Chave as Chief Technologist
[ Tue, Oct 26th 2010 ]: Market Wire
ICON Announces Appointment of Cathrin Petty to Board of Directors
Mon, October 25, 2010
[ Mon, Oct 25th 2010 ]: Market Wire
Ligand to Present at the Oppenheimer 21st Annual Healthcare Conference on November 2
[ Mon, Oct 25th 2010 ]: Market Wire
Quest PharmaTech Announces Treasury Issue of Common Shares
[ Mon, Oct 25th 2010 ]: Market Wire
Synovis Life Technologies to Present at the Singu .. l Best of the Uncovereds Conference on November 4
[ Mon, Oct 25th 2010 ]: Market Wire
Abiomed Second Quarter Fiscal 2011 Earnings and Conference Call Notification
[ Mon, Oct 25th 2010 ]: Market Wire
Helicos BioSciences Amends Patent Infringement La .. ciences to Include Illumina and Life Technologies
[ Mon, Oct 25th 2010 ]: Market Wire
Emeritus to Acquire Rehab Therapy Services Group
[ Mon, Oct 25th 2010 ]: Market Wire
Seattle Genetics and Millennium to Highlight Bren .. t the International Symposium on Hodgkin Lymphoma
[ Mon, Oct 25th 2010 ]: Market Wire
BioCryst to Present at Oppenheimer Healthcare Conference
[ Mon, Oct 25th 2010 ]: Market Wire
Bestuur Alcon kiest nieuwe voorzitter
[ Mon, Oct 25th 2010 ]: Market Wire
AngioDynamics to Participate at the 21st Annual Oppenheimer Healthcare Conference
[ Mon, Oct 25th 2010 ]: Market Wire
Il Consiglio di amministrazione di Alcon nomina il suo nuovo Presidente
[ Mon, Oct 25th 2010 ]: Market Wire
Junta de Alcon elige nuevo presidente
[ Mon, Oct 25th 2010 ]: Market Wire
Alcon-Verwaltungsrat whlt neuen Vorsitzenden
[ Mon, Oct 25th 2010 ]: Market Wire
Conselho da Alcon elege novo presidente
Sun, October 24, 2010
[ Sun, Oct 24th 2010 ]: Market Wire
Gileada?s Cayston® superieur aan Tobramycine inh .. anden durende head-to-head cystic fibrosis studie
[ Sun, Oct 24th 2010 ]: Market Wire
Alcon Board Elects New Chairman
[ Sun, Oct 24th 2010 ]: Market Wire
HERBALIFE LANZA NUEVOS PRODUCTOS INCLUYENDO BATID .. EINA SIN ALERGENOS Y SUPLEMENTO NUTRICIONAL COQ10
Sat, October 23, 2010
[ Sat, Oct 23rd 2010 ]: Market Wire
Dr. Reddya?s Q2 FY11 Financial Results
Fri, October 22, 2010
[ Fri, Oct 22nd 2010 ]: Market Wire
Cayston® di Gilead si dimostrato superiore alla .. alazione in uno studio di raffronto diretto della
[ Fri, Oct 22nd 2010 ]: Market Wire
Cayston® von Gilead zeigt in sechsmonatiger Kopf .. Fibrose berlegenheit gegenber Tobramycin-Inhalat
[ Fri, Oct 22nd 2010 ]: Market Wire
Law Offices of Howard G. Smith Announces Investig .. rs of Clarient, Inc. in Connection with the Propo
[ Fri, Oct 22nd 2010 ]: Market Wire
MannKind Corporation to Hold 2010 Third Quarter F .. ncial Results Conference Call on October 29, 2010
[ Fri, Oct 22nd 2010 ]: Market Wire
Sycamore Entertainment Group Launches New Corporate Website
[ Fri, Oct 22nd 2010 ]: Market Wire
Faruqi & Faruqi, LLP Announces Investigation Related to the Acquisition of Clarient Inc. a" CLRT
[ Fri, Oct 22nd 2010 ]: Market Wire
Clarient, Inc. Shareholder Investigation by Brisc .. Regarding the Buyout by General Electric Company
[ Fri, Oct 22nd 2010 ]: Market Wire
Cardiac Science Shareholder Investigation by Bris .. ing the Merger with Opto Circuits (India) Limited
[ Fri, Oct 22nd 2010 ]: Market Wire
Kendall Law Group Investigates Clarient, Inc. Acquisition for Shareholders
[ Fri, Oct 22nd 2010 ]: Market Wire
Wright Medical Group, Inc. Announces Full Commerc .. f PRO-STIMa" Osteoinductive Bone Graft Substitute
[ Fri, Oct 22nd 2010 ]: Market Wire
Health Net Federal Services Awarded Department of .. ns Affairs CBO Outpatient Recovery Audit Contract
[ Fri, Oct 22nd 2010 ]: Market Wire
St. Jude Medical Board of Directors Authorizes Share Repurchase
[ Fri, Oct 22nd 2010 ]: Market Wire
Biogen Idec en Genentech melden herstructurering anti-CD20 samenwerkingsovereenkomst
[ Fri, Oct 22nd 2010 ]: Market Wire
Biogen Idec y Genentech anuncian modificacin en su acuerdo de colaboracin de anticuerpos anti-CD20
Thu, October 21, 2010
[ Thu, Oct 21st 2010 ]: Market Wire
The Shuman Law Firm Announces the Filing of a Cla .. ction Lawsuit against Acura Pharmaceuticals, Inc.
[ Thu, Oct 21st 2010 ]: Market Wire
Wright Medical Group, Inc. to Host Third Quarter 2010 Earnings Conference Call
[ Thu, Oct 21st 2010 ]: Market Wire
Gileada?s Cayston® Superior to Tobramycin Inhala .. n in Six-Month Head-to-Head Cystic Fibrosis Study
[ Thu, Oct 21st 2010 ]: Market Wire
CardioNet, Inc. to Release Third Quarter 2010 Earnings Results on November 8, 2010
[ Thu, Oct 21st 2010 ]: Market Wire
Neoprobe Files Response to FDA Review Letter of RIGScana" Biologic License Application
[ Thu, Oct 21st 2010 ]: Market Wire
Emergency Medical Services to Host Conference Cal .. sults for Third Quarter Ending September 30, 2010
[ Thu, Oct 21st 2010 ]: Market Wire
Merit Medical Systems to Announce Third Quarter Results on November 4, 2010
[ Thu, Oct 21st 2010 ]: Market Wire
Apricus Biosciences to Present at the FSX Investor Conference in Phoenix, AZ on October 29, 2010
[ Thu, Oct 21st 2010 ]: Market Wire
A Significant Step Closer to Commercialization
[ Thu, Oct 21st 2010 ]: Market Wire
Idera Pharmaceuticals Presents Phase 1 Clinical D .. ate for the Treatment of Autoimmune Diseases, and
[ Thu, Oct 21st 2010 ]: Market Wire
IntegraMed® to Participate at Fifth Annual Singu .. h Best of The Uncovereds Conference on November 4
[ Thu, Oct 21st 2010 ]: Market Wire
PerkinElmer to Hold Earnings Call on Thursday, November 4, 2010
[ Thu, Oct 21st 2010 ]: Market Wire
Curis to Release Third Quarter 2010 Financial Results and Hold Conference Call on October 28, 2010
[ Thu, Oct 21st 2010 ]: Market Wire
Cardiome Announces Suspension of Enrollment in ACT 5 Trial

Ligand to Report Third Quarter Results on November 9

  Copy link into your clipboard //health-fitness.news-articles.net/content/2010/ .. -report-third-quarter-results-on-november-9.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

SAN DIEGO--([ BUSINESS WIRE ])--Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced today plans to report third quarter 2010 financial results on Tuesday, November 9, 2010. Liganda™s President and CEO, John L. Higgins and Vice President of Finance and CFO, John Sharp will host the conference call.

Third Quarter Earnings Call

What: Ligand Pharmaceuticals conference call to discuss financial results and provide general business updates.
When: Tuesday, November 9, 2010
Time: 1:30 p.m. Pacific time (4:30 p.m. Eastern time)
Webcast:

Conference call and replay accessible at [ www.ligand.com ].

Conference Call: (877) 407-4019, passcode: Ligand
(201) 689-8337 outside the U.S.
Replay: (877) 660-6853, Account #: 361 passcode: 359601 (201) 612-7415 outside the U.S.

About Ligand Pharmaceuticals

Ligand discovers and develops novel drugs that address critical unmet medical needs of patients for a broad spectrum of diseases including hepatitis, muscle wasting, Alzheimer's disease, dyslipidemia, diabetes, anemia, COPD, asthma, rheumatoid arthritis and osteoporosis. Ligand's proprietary drug discovery and development programs are based on advanced cell-based assays, tissue-specific receptor ligand interactions and gene-expression tools. Among its peers, we believe Ligand has assembled one of the largest portfolio of assets including commercial therapies developed in partnership with pharmaceutical companies. Ligand has alliances with the world's leading pharmaceutical companies including GlaxoSmithKline (GSK), Merck, Pfizer, Roche, Bristol-Myers Squibb and AstraZeneca, and has more than 30 programs in various stages of development.